| PERIOD ENDING | 30-Sep-09 | 28-Jun-09 | 29-Mar-09 | 31-Dec-08 | | Total Revenue | 111,371 | 80,886 | 81,548 | 151,917 | | Cost of Revenue | 107,149 | 92,942 | 96,061 | 155,588 | | | Gross Profit | 4,222 | (12,056) | (14,513) | (3,671) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,781 | 5,838 | 4,775 | 6,447 | | Non Recurring |
-
| 2,894 | 8,910 | 13,457 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,559) | (20,788) | (28,198) | (23,575) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,662 | (794) | (901) | 6,651 | | Earnings Before Interest And Taxes | 103 | (21,582) | (29,099) | (16,924) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 103 | (21,582) | (29,099) | (16,924) | | Income Tax Expense | 8,772 | (2,817) | 26,460 | 1,375 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (12,741) | (20,969) | (56,501) | (20,119) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (12,741) | (20,969) | (56,501) | (20,119) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($12,741) | ($20,969) | ($56,501) | ($20,119) |
|
0.16% Nasdaq 
Income Statement
